Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for Breast Cancer
22 locations incl. Duarte
Sponsor: Celcuity Inc
Sex: All·Age: 18+
Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025